Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,614.00
Bid: 2,620.00
Ask: 2,622.00
Change: -22.00 (-0.83%)
Spread: 2.00 (0.076%)
Open: 2,640.00
High: 2,644.00
Low: 2,614.00
Prev. Close: 2,636.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Move to organic reporting

12 Apr 2022 17:38

RNS Number : 1817I
Coca-Cola HBC AG
12 April 2022
 

Coca-Cola HBC AG

Move to organic reporting

 

 

Zug, Switzerland - 12 April 2022 - As previously announced at the time of Coca-Cola HBC's full year 2021 results, we have moved our key reporting measures as of 1 January 2022 to organic growth metrics. This is to enable a better understanding of underlying business performance, that is more consistent with how Coca-Cola HBC's peer group reports.

 

To facilitate comparison with prior-year periods, we are providing restated key reporting figures for 2021 reflecting the new organic metrics. The change to organic reporting does not affect the Group's primary annual audited, or interim, financial statements.

 

Going forward we will provide reported and organic growth metrics as our main KPIs. All Comparable and Other KPIs will remain, and we will also disclose Organic volume growth, Organic net sales revenue and Organic net sales revenue per unit case growth, Organic Comparable EBIT growth, and Organic Comparable EBIT margin change. Definitions of the new metrics are included in this release.

 

The information contained in this release does not constitute or imply guidance on the Group's current financial year which remains withdrawn further to our announcement on 3 March 2022.

 

Definitions of Alternative Performance Measures ("APMs"):

 

Organic growth

Organic growth enables users to focus on the operating performance of the business on a basis which is not affected by changes in foreign currency exchange rates from period to period or changes in the Group's scope of consolidation ("consolidation perimeter") i.e. acquisitions, divestments and reorganisations resulting in equity method accounting. Thus, organic growth is designed to assist users in better understanding the Group's underlying performance.

 

More specifically, the following items are adjusted from the Group's volume, net sales revenue and comparable EBIT in order to derive organic growth metrics:

 

(a) Foreign Currency impact

Foreign Currency impact in the organic growth calculation reflects the adjustment of prior-period net sales revenue and comparable EBIT metrics for the impact of changes in exchange rates applicable to the current period.

 

(b) Consolidation perimeter impact

Current period volume, net sales revenue and comparable EBIT metrics, are each adjusted for the impact of changes in the consolidation perimeter. More specifically adjustments are performed as follows:

 

i. Acquisitions:

For current year acquisitions, the results generated in the current period by the acquired entities are not included in the organic growth calculation. For prior year acquisitions, the results generated in the current year over the period during which the acquired entities were not consolidated in the prior year, are not included in the organic growth calculation.

 

ii. Divestments:

For current year divestments, the results generated in the prior year by the divested entities over the period during which the divested entities are no longer consolidated in the current year, are included in the current year's results for the purpose of the organic growth calculation. Forprior-year divestments, the results generated in the prior year by the divested entities over the period during which the divested entities were consolidated, are included in the current year's results for the purpose of the organic growth calculation. Any gains or losses on divestments are excluded from the organic growth calculation.

 

iii. Reorganisations resulting in equity method accounting:

For current year reorganisations where the Group maintains either joint control or significant influence over the relevant entities so that they are reclassified from subsidiaries or joint operations to joint ventures or associates and accounted for under the equity method, the results generated in the current year by the relevant entities over the period during which these entities are no longer consolidated, are included in the current year's results for the purpose of the organic growth calculation. For such reorganisations in the prior year, the results generated in the current year by the relevant entities over the period during which these entities were consolidated in the prior year, are included in the current year's results for the purpose of the organic growth calculation. In addition, the share of results in the current year of the relevant entities, for the respective period as described above, is excluded from the organic growth calculation for such reorganisations. Any gains or losses on such reorganisations are excluded from the organic growth calculation.

 

 

 

 

ORGANIC METRICS 2021 (RESTATED)

Q1 2021

H1 2021

Q3 2021

FY 2021

Organic volume growth (%)

Established

-4.7%

11.8%

8.0%

9.9%

Developing

-11.4%

0.6%

-1.9%

0.8%

Emerging

14.5%

22.9%

21.3%

20.4%

Group organic volume growth

4.7%

15.9%

13.1%

14.0%

Organic net sales revenue per unit case growth (%)

Established

1.5%

4.8%

1.7%

3.7%

Developing

8.9%

16.9%

14.0%

17.0%

Emerging

3.2%

6.1%

3.9%

5.6%

Group organic net sales revenue per unit case growth

1.3%

6.2%

3.5%

5.8%

Organic net sales revenue growth (%)

Established

-3.2%

17.1%

9.8%

13.9%

Developing

-3.5%

17.6%

11.8%

18.0%

Emerging

18.3%

30.3%

26.1%

27.1%

Group organic net sales revenue growth

6.1%

23.1%

17.1%

20.6%

Organic Comparable EBIT growth (%)

Established

>100%

43.6%

Developing

78.8%

6.3%

Emerging

60.8%

20.4%

Group Organic Comparable EBIT growth

77.4%

25.6%

Organic Comparable EBIT margin change (bps)

Established

440

250

Developing

190

-90

Emerging

250

-70

Group Organic Comparable EBIT margin change

320

50

 

 

 

 

Enquiries

 

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

 

Tel: +44 7802 427505

 joanna.kennedy@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Marios Matar

Investor Relations Manager

Tel: +30 697 444 3335

marios.matar@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the communities in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve 715 million consumers across a broad geographic footprint of 29 countries on three continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading beverage brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These beverages include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Costa, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our 36,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUONRUVUSAAR
Date   Source Headline
3rd May 20245:25 pmRNSTransaction in Own Shares
3rd May 202412:46 pmRNSDirector/PDMR Shareholding
3rd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20245:41 pmRNSTransaction in Own Shares
2nd May 202412:40 pmRNSAthens Exchange trading date of ordinary shares
1st May 20245:47 pmRNSTransaction in Own Shares
1st May 202410:09 amRNSBlock listing Interim Review
1st May 20249:10 amRNSIssue of equity and total voting rights
30th Apr 20247:00 amRNSStrong start; reiterating 2024 guidance
19th Apr 20249:20 amRNSNotice of AGM
18th Apr 20244:21 pmRNSDirector/PDMR Shareholding
5th Apr 20242:17 pmRNSNotice of Results
2nd Apr 202411:12 amRNSIssue of equity and total voting rights
28th Mar 20245:55 pmRNSDirector/PDMR Shareholding
28th Mar 20245:47 pmRNSDirector/PDMR Shareholding
28th Mar 20245:42 pmRNSDirector/PDMR Shareholding
28th Mar 20245:26 pmRNSTransaction in Own Shares
27th Mar 20245:23 pmRNSTransaction in Own Shares
26th Mar 20245:05 pmRNSTransaction in Own Shares
26th Mar 20249:09 amRNSDirector/PDMR Shareholding
25th Mar 20245:10 pmRNSTransaction in Own Shares
22nd Mar 20245:27 pmRNSTransaction in Own Shares - Replacement
22nd Mar 20245:05 pmRNSTransaction in Own Shares
21st Mar 20245:40 pmRNSTransaction in Own Shares
20th Mar 20245:33 pmRNSTransaction in Own Shares
19th Mar 20245:20 pmRNSTransaction in Own Shares
19th Mar 20241:19 pmRNSDirector/PDMR Shareholding
18th Mar 20245:20 pmRNSTransaction in Own Shares
15th Mar 20246:25 pmRNSTransaction in Own Shares
15th Mar 20245:58 pmRNSAnnual Financial Report
14th Mar 20245:30 pmRNSTransaction in Own Shares
14th Mar 20243:04 pmRNSDirector/PDMR Shareholding
14th Mar 20242:56 pmRNSDirector/PDMR Shareholding
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:15 pmRNSTransaction in Own Shares
11th Mar 20245:50 pmRNSTransaction in Own Shares
8th Mar 20245:45 pmRNSTransaction in Own Shares
7th Mar 20245:20 pmRNSTransaction in Own Shares
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20245:15 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares
1st Mar 20245:15 pmRNSTransaction in Own Shares
1st Mar 20249:25 amRNSIssue of Equity and total voting rights
29th Feb 20245:25 pmRNSTransaction in Own Shares
29th Feb 20243:10 pmRNSDirector/PDMR Shareholding
29th Feb 20243:00 pmRNSDirector/PDMR Shareholding
29th Feb 20242:53 pmRNSDirector/PDMR Shareholding
28th Feb 20245:25 pmRNSTransaction in Own Shares
27th Feb 20245:35 pmRNSTransaction in Own Shares
26th Feb 20245:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.